CD28nullCD4+ T cells - Characterization of an effector memory T-cell population in patients with rheumatoid arthritis

Scandinavian Journal of Immunology

Volumn 60, Issue 1, 2004, Pages 199-208

  Fasth, A E R ^a   Cao, D ^a   Van Vollenhoven, R ^a   Trollmo, C ^a   Malmstrom V ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR7; HLA DR ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD; CELL POPULATION; CELL PROLIFERATION; CELL SURFACE; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGENS, CD28; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 3242669036     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01464.x     Document Type: Article

References (34)

1. Byrne JA, Butler JL, Cooper MD. Differential activation requirements for virgin and memory T cells. J Immunol 1988;141 (10):3249-57.
2. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002;2 (2):116-26.
3. Berard M, Tough DF. Qualitative differences between naive and memory T cells. Immunology 2002;106 (2):127-38.
4. Tarazona R, DelaRosa O, Alonso C et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev 2000;121 (1-3):77-88.
5. Kaneko H, Saito K, Hashimoto H, Yagita H, Okumura K, Azuma M. Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. Clin Exp Immunol 1996;106 (2):218-29.
6. Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R. CD4+CD28- costimulation-independent T cells in multiple sclerosis. J Clin Invest 2001;108 (8):1185-94.
7. Weyand CM, Goronzy JJ. T-cell responses in rheumatoid arthritis: systemic abnormalities-local disease. Curr Opin Rheumatol 1999;11 (3):210-7.
8. Dupuy d'Angeac A, Monier S, Jorgensen C et al. Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum 1993;36 (5):608-12.
9. Hooper M, Kallas EG, Coffin D, Campbell D, Evans TG, Looney RJ. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J Rheumatol 1999;26 (7):1452-7.
10. Maeda T, Yamada H, Nagamine R et al. Involvement of CD4+CD57+ T cells in the disease activity of rheumatoid arthritis. Arthritis Rheum 2002;46 (2):379-84.
11. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM. CD4+CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 2001;44 (1):13-20.
12. Morishita Y, Sao H, Hansen JA, Martin PJ. A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire. J Immunol 1989;143 (9):2783-9.
13. Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97 (9):2027-37.
14. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Snyder MR, Muegge LO, Offord C et al. Formation of the killer Ig-like receptor repertoire on CD4+CD28null T cells. J Immunol 2002;168 (8):3839-46.
16. Nakajima T, Goek O, Zhang X et al. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 2003;93 (2):106-13.
17. Weyand CM, Goronzy JJ. Premature immunosenescence in rheumatoid arthritis. J Rheumatol 2002;29 (6):1141-6.
18. Ross GD. Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion. Immunol Res 2002;25 (3):219-27.
19. Wagner C, Hansch GM, Stegmaier S, Denefleh B, Hug F, Schoels M. The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function. Eur J Immunol 2001;31 (4):1173-80.
20. Brenchley JM, Karandikar NJ, Betts MR et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003;101 (7):2711-20.
21. Stetson DsB, Mohrs M, Reinhardt RL et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 2003;198 (7):1069-76.
22. Lantz O, Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 1994;180 (3):1097-106.
23. Chapman A, Stewart SJ, Nepom GT et al. CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles. J Immunol 1996;157 (11):4771-80.
24. van der Heide A, Remme CA, Hofman DM, Jacobs JW, Bijlsma JW. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38 (10):1466-74.
25. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401 (6754):708-12.
26. Ohara T, Koyama K, Kusunoki Y et al. Memory functions and death proneness in three CD4+CD45RO+ human T cell subsets. J Immunol 2002;169 (1):39-48.
27. Kassiotis G, Zamoyska R, Stockinger B. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J Exp Med 2003;197 (8):1007-16.
28. Vallejo AN, Schirmer M, Weyand CM, Goronzy JJ. Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways. J Immunol 2000;165 (11):6301-7.
29. Wagner U, Pierer M, Kaltenhauser S et al. Clonally expanded CD4+CD28null T cells in rheumatoid arthritis use distinct combinations of T cell receptor BV and BJ elements. Eur J Immunol 2003:33 (1):79-84.
30. Valenzuela HF, Effros RB. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin Immunol 2002;105 (2):117-25.
31. Topp MS, Riddell SR, Akatsuka Y, Jensen MC, Blattman JN, Greenberg PD. Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production. J Exp Med 2003;198 (6):947-55.
32. Champagne P, Ogg GS, King AS et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001;410 (6824):106-11.
33. Namekawa T, Wagner UG, Goronzy JJ, Weyand CM. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum 1998;41 (12):2108-16.
34. Sfikakis PP, Zografou A, Viglis V et al. CD28 expression on T cell subsets in vivo and CD28-mediated T cell response in vitro in patients with rheumatoid arthritis. Arthritis Rheum 1995;38 (5):649-54.